Associated Papers
A new AMPK activator, GSK773, corrects fatty acid oxidation and differentiation defect in CPT2-deficient myotubes.
Boufroura FZ et al.
Human Molecular Genetics, 2018
Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency.
Bonnefont JP et al.
Clinical Pharmacology and Therapeutics, 2010
Select a paper to view details